Fig. 1From: Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot studyStudy workflow. Starting with collection of fecal samples, and genomic DNA extraction at Genetic Analysis (GA), through analysis of the DNA samples on the two different platforms: LUMI-Seq™ (Long 16S using Unique Molecular Identifiers – Sequencing) at BIOASTER and the GA-map® Technology Platform 131-plex at GABack to article page